Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al

Romaric Larcher; Paul Laffont-Lozes; Paul Loubet; Didier Laureillard; Tayma Naciri; Albert Sotto

doi:10.1016/j.cmi.2023.01.022

Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al

Clin Microbiol Infect. 2023 Jun;29(6):808-811. doi: 10.1016/j.cmi.2023.01.022. Epub 2023 Feb 3.

Authors

Romaric Larcher¹, Paul Laffont-Lozes², Paul Loubet³, Didier Laureillard⁴, Tayma Naciri⁴, Albert Sotto³

Affiliations

¹ PhyMedExp (Physiology and Experimental Medicine), INSERM (French Institute of Health and Medical Research), CNRS (French National Centre for Scientiﬁc Research), University of Montpellier, France and Department of Infectious and Tropical Diseases, Nîmes University Hospital, France. Electronic address: [email protected].
² Department of Infectious and Tropical Diseases and Department of Pharmacy, Nîmes University Hospital, France.
³ VBIC (Bacterial Virulence and Chronic Infection), INSERM (French Institute of Health and Medical Research), Montpellier University, Department of Infectious and Tropical Diseases, Nîmes University Hospital, France.
⁴ Department of Infectious and Tropical Diseases, Nîmes University Hospital, France.

PMID: 36739087
DOI: 10.1016/j.cmi.2023.01.022

No abstract available

Keywords: Antimicrobial susceptibility testing; Bloodstream infection; Cefiderocol; Combination therapy; Heteroresistance; Immunocompromised patient; Nonfermenters. outcomes.

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Cefiderocol
Cephalosporins* / pharmacology
Cephalosporins* / therapeutic use
Drug Resistance, Multiple, Bacterial
Gram-Negative Bacteria
Gram-Negative Bacterial Infections* / drug therapy
Gram-Negative Bacterial Infections* / microbiology
Humans
Microbial Sensitivity Tests

Substances

Cephalosporins
Anti-Bacterial Agents